GGrantIndex
← Leaderboards

Jennifer A. Ligibel

Pennsylvania State Univ Hershey Med Ctr

$3,611,711
Attributed
$9,316,038
Total exposure
3
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY202225
$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25

Funding mix

By agency

NIH$9,316,038 · 3

By mechanism

U01$4,864,970 · 1
R01$3,777,161 · 1
U34$673,907 · 1

Top collaborators

Most similar at Pennsylvania State Univ Hershey Med Ctr

Same institution · by research overlap

Others in their field

Other Rising Stars on “Physical Function

Research focus

Physical FunctionEvaluationExercisePreservationChemotherapyExercise InterventionCancer TherapyTreatment-Related ToxicityMental DepressionWomanDoseFatigueMalignant Breast NeoplasmImproved OutcomeRandomizedParticipantSleepAttenuatedDietPsychologicQuality Of LifePatient Outcomes AssessmentsToxic EffectCancer Patient

Grant awards (10)

Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$2,233,701
R01 · FY2025 · CA
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)$1,211,647
U01 · FY2025 · CA
Distance-based Exercise to preserve Function and prevENt Disability (DEFEND)$379,120
U34 · FY2025 · CA · contact PI
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)$1,152,637
U01 · FY2024 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$732,901
R01 · FY2024 · CA
Distance-based Exercise to preserve Function and prevENt Disability (DEFEND)$294,787
U34 · FY2024 · CA · contact PI
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)$1,192,630
U01 · FY2023 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$810,559
R01 · FY2023 · CA
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)$939,463
U01 · FY2022 · CA
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)$368,593
U01 · FY2022 · CA